Ticker Scorecard - PTCT Basics Company: PTC Therapeutics, Inc. IPO Date: June 20, 2013 Sector: Healthcare Industry: Biotech Activated in VL: True Average Daily Range Avg Daily Range: $0.85 | 2.70% Avg Daily Range (30 D): $0.82 | 1.75% Avg Daily Range (90 D): $0.94 | 2.11% Institutional Daily Volume Avg Daily Volume: .71M Avg Daily Volume (30 D): .55M Avg Daily Volume (90 D): .58M Trade Size Avg Trade Size (Sh.): 95 Avg Trade Size (Sh.) (30 D): 52 Avg Trade Size (Sh.) (90 D): 56 Institutional Trades Total Inst.Trades: 6,584 Avg Inst. Trade: $2.33M Avg Inst. Trade (30 D): $2.73M Avg Inst. Trade (90 D): $2.35M Avg Inst. Trade Volume: .06M Avg Inst. Trades (Per Day): 2 Market Closing Trades Avg Closing Trade: $3.6M Avg Closing Trade (30 D): $4.46M Avg Closing Trade (90 D): $4.75M Avg Closing Volume: 96.84K     News Aug 3, 2024 @ 7:41 PM SHAREHOLDER ALERT: Pomerantz Law Firm Investigates... Source: N/A Jul 9, 2024 @ 6:01 PM PTC Therapeutics, Inc. (PTCT) Investigation: Brons... Source: Bronstein, Gewirtz & Grossman, Llc Jul 1, 2024 @ 12:00 PM PTC Therapeutics (PTCT) Down on Negative CHMP Opin... Source: Zacks Equity Research Jun 24, 2024 @ 8:44 AM PTC Therapeutics (PTCT) Soars 9.7%: Is Further Ups... Source: Zacks Equity Research May 24, 2024 @ 1:38 PM The Zacks Analyst Blog Highlights Biogen, Ionis Ph... Source: Zacks Equity Research Financials   TTM Q3 2024 Q2 2024 Basic EPS $-5.94 $-1.39 $-1.29 Diluted EPS $-5.94 $-1.39 $-1.29 Revenue $ 900.66M $ 196.79M $ 186.7M Gross Profit $ $ $ Net Income / Loss $ -453.2M $ -106.65M $ -99.18M Operating Income / Loss $ -134.36M $ -54.51M $ -40.22M Cost of Revenue $ $ $ Net Cash Flow $ 353.96M $ -137.29M $ 109.11M PE Ratio